Fig. 1.1 Number of transplants and size of active waiting list This rise is attributable to the increasing number of waiting patients bridged with mechanical circulatory support devices . In…
Fig. 8.1 HeartMate III fully magnetically levitated left ventricular assist system The rotor is fully supported by magnetic levitation, obviating mechanical or fluid bearings. Both drive (i.e., rotation) and levitation…
1. Severe symptoms of HF with dyspnea and/or fatigue at rest or with minimal exertion (NYHA functional class III or IV) 2. Episodes of fluid retention (pulmonary and/or systemic congestion,…
Fig. 7.1 Heart failure and LVAD physiology. Ao aorta, PA pulmonary artery, LVAD left ventricular assist device, MR mitral regurgitation, TR tricuspid regurgitation, CO cardiac output, CVP central venous pressure,…
Fig. 6.1 Kaplan–Meier survival by era (adult heart transplants, January 1982 to June 2010) [4] One-year mortality following transplant has been associated with advanced donor age and recipient risk factors…
References Dates Device # Indication Criteria Data type Statistics El-Banayosy et al. [2] 1992–2000 Thoratec 104 BTT >60 Bad Oeynhausen OR 3.87 Dang (2001) 1993–1999 Novacor 464 BTT >65 Registry…
Fig. 4.1 Cost of medical therapy for end-stage heart failure patients during last 2 years of life by 3 month time periods as a percentage of the total cost 4.2.2…
Patient profile Patient characteristics 1 Critical cardiogenic shock despite escalating support 2 Progressive decline with inotrope dependence 3 Clinically stable with mild to moderate inotrope dependence 4 Recurrent, not refractory,…
